Navin Fluorine International Limited · NSE:NAVINFLUOR

Navin Fluorine International — Q1 FY17 Earnings Presentation

19 slides from Navin Fluorine International's earnings presentation

  1. Slide 1: Navin Fluorine International Limited Result Update Presentation Q1 FY17

    Navin Fluorine International Limited Result Update Presentation Q1 FY17

  2. Slide 2: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Navin Fluorine International Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe

  3. Slide 3: Journey Up the Value Chain Gains Momentum

    Journey Up the Value Chain Gains Momentum... ...Driven by Business, Product & Geography Mix 3 Note: Q1 FY17 Results compared with Q1FY16

  4. Slide 4: Standalone Profitability Statement

    Standalone Profitability Statement Rs. Crs. Q1 FY17 Q1 FY16 Change % Revenue 164 150 9% Raw Material 65 71 Employee Expenses 18 16 Other Expenses 41 38 Operating EBITDA 40 26 55% Operating EBITDA Margin 24.2% 17.0% 714bps Interest Expenses 0 0 Depreciation 6 5 Operating PBT 34 21 64% Operating PBT M

  5. Slide 5: Revenue Mix: Business Unit Wise

    Revenue Mix : Business Unit Wise 7% 12% 37% 32% 16% 16% 40% 40% Q1 FY16 Q1 FY17 CRAMS Inorganic Fluorides Specialty Chemicals Refrigerant Gases 5 * Standalone Results

  6. Slide 6: Business Units Performance: Refrigerants and Inorganic Fluorides

    Business Units Performance Refrigerants Inorganic Fluorides Revenue (Rs.Crs) 215 113 105 195 194 98 99 94 176 154 66 26 FY12 FY13 FY14 FY15 FY16 Q1 FY17 FY12 FY13 FY14 FY15 FY16 Q1 FY17 Exports Exports 5% Geographic Mix – Q1 FY17 21% Domestic 95% Domestic 79% 6 * Standalone Results

  7. Slide 7: Business Units Performance: Specialty Chemicals and CRAMS

    Business Units Performance Specialty Chemicals CRAMS** Revenue (Rs.Crs) 239 87 215 178 159 156 26 31 53 14 19 FY12 FY13 FY14 FY15 FY16 Q1 FY17 FY13 FY14 FY15 FY16 Q1 FY17 Domestic 0% Exports Geographic Mix – Q1 FY17 38% Exports 100% Domestic 62% 7 ** CRAMS business generating revenue since FY13 * St

  8. Slide 8: Key Updates

    Key Updates Manufacturing Facility at Dewas • India’s only plant with cGMP compliant capabilities for high pressure 01 fluorination • Numerous Customer Audits completed successfully • Plant commercially operational Greenfield Facility at Dahej, Gujarat • JV with Piramal Enterprises Ltd. to develop,

  9. Slide 9: Business Overview

    Responsible Care” Business Overview rN Wh ARVIND MAFATLAL GROUP

  10. Slide 10: Overview

    Overview Built “India’s only plant with high pressure fluorination capabilities with Largest Integrated Specialty cGMP compliance” for CRAMS Business Fluorochemical Company in India Manufacturing plants Over 45 years of expertise strategically located in Handling Fluorine closer to major ports Stron

  11. Slide 11: Business Units (BU) - Standalone

    Business Units (BU) - Standalone FY11 – Revenue % FY16 – Revenue % Commenced CRAMS business in 2011 CRAMS – 0% CRAMS – 14% Commenced Specialty Chemicals in Specialty Specialty 2000 Chemicals – 27% Chemicals – 38% Inorganic Fluorides & Refrigerants are Refrigerants (incl. Refrigerants – traditional b

  12. Slide 12: Clients across the Globe

    & e Clients across the Globe Ne ; UJ CLARIANT™ Cs) Bayer syngenta Cs) Bayer CropScience 2. PHARMACEUTICAL anaadl Bem. —_INDUSTRIESLTD. eo LUPIN AUROBINDO ‘Committed to Healthier Life e ae Y Dr.ReDpy's LIFE. RESEARCH . HOPE 12 ARVIND MAFATLAL GROUP

  13. Slide 13: Key Strengths

    Key Strengths Fluorination Capabilities In-house R&D  Pioneered Manufacturing of  State-of-the-art R&D centre – Navin Refrigerant Gases in India Research Innovation Centre at Surat  Over 45 years of experience in  DSIR approved R&D Centre handling Fluorine  Supports in product addition &  Exte

  14. Slide 14: Growth driven by Every Business Unit

    Growth driven by Every Business Unit CRAMS  Business progression from Contract Research to Contract Manufacturing  cGMP compliant manufacturing facility operational Specialty Chemicals  Introduction of new high value added molecules in portfolio  Entry into newer geographies Inorganic Fluorides

  15. Slide 15: Strategy Begins to Yield Results

    Strategy Begins to Yield Results Operating EBITDA Margin (%) Operating PBT Margin (%) 18% 14% 15% 13% 10% 12% 8% 8% FY13 FY14 FY15 FY16 FY13 FY14 FY15 FY16 Return on Net Worth (%) Return on Capital Employed (%) 14% 18% 10% 12% 9% 9% 11% 11% FY13 FY14 FY15 FY16 FY13 FY14 FY15 FY16 15 * Standalone Res

  16. Slide 16: Consolidated Profitability Statement

    Consolidated Profitability Statement Rs. Crs. FY16 FY15 Change % Revenue 680 592 15% Raw Material 311 289 Employee Expenses 81 74 Other Expenses 171 156 EBITDA 117 72 63% EBITDA Margin 17.3% 12.2% 506 bps Interest Expenses 4 3 Depreciation 22 20 Operating PBT 91 49 87% Operating PBT Margin 13.4% 8.2

  17. Slide 17: Consolidated Balance Sheet

    Consolidated Balance Sheet Rs. Crs. Mar’16 Mar’15 Shareholder’s Fund Share capital 10 10 Reserves & Surplus 636 578 Minority Interest - 13 Non-current liabilities Long term borrowings 48 27 Deferred Tax Liabilities (net) 37 32 Other non-current liabilities 29 28 Current liabilities Short term borrow

  18. Slide 18: Consistent Dividend Performance

    Consistent Dividend Performance Dividend as % of Face Value Robust Dividend Payout Declared Highest ever Total Dividend @ 210% Interim Final  Continuous Dividend since last 10 years 160% 160% 150% 150% 150% 140%  Special Dividend of Rs. 60 per share in FY 12  Declared Final Dividend of Rs.11 per

  19. Slide 19: Contact

    Contact For further information, please contact: Company : Investor Relations Advisors : Navin Fluorine International Ltd. Strategic Growth Advisors Pvt. Ltd. CIN : L24110MH1998PLC115499 CIN : U74140MH2010PTC204285 Mr. Sitendu Nagchaudhuri Ms. Sanjita Ghosh / Mr. Shogun Jain Chief Financial Officer

Navin Fluorine International — Q1 FY17 Earnings Presentation on 6ix